Skip to main content

Advertisement

SpringerLink
Log in

Current investigations and treatment of interstitial cystitis

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Interstitial cystitis (IC) is a chronic condition characterized by a constellation of symptoms such as urinary frequency, nocturia, urinary urgency, suprapubic pressure, and bladder and pelvic pain. Since its original description, the etiology of the disorder has remained unknown despite intense investigations. The International Cystitis Association (ICA) and the National Institutes of Arthritis, Diabetes, Digestive and Kidney Diseases (NIDDK) have been instrumental in supporting the United States Interstitial Database (ICDB) and foster research to study the disorder. The NIDDK developed criteria to ensure that all groups of patients treated would be relatively comparable. However, many patients who would be clinically considered to have IC do not fulfill all the NIDDK criteria. Many clinical criteria for the diagnosis of IC, such as the presence of glomerulations and the intravesical potassium chloride test, are being challenged. The epidemiology of the disorder is not well established, but there are an estimated 700,000 cases of IC in the United States. Numerous pathophysiologic mechanisms have been proposed, but none have been proven. There is no representative animal model of IC. Both the oral and intravesical treatments of IC are noncurative, and few are based on a plausible mechanism or scientific evidence. Surgical treatment should be considered with extreme caution; it is the last therapeutic option because failure rate can be substantial.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Pontari MA, Hanno PM, Wein A: Logical and systematic approach to the evaluation and management of patients suspected of having interstitial cystitis. Urology 1997, 49(suppl):114–119.

    Article  PubMed  CAS  Google Scholar 

  2. Perez-Marrero R, Emerson L, Juma S: Urodynamic studies in interstitial cystitis. Urology 1987, 29:27–30.

    PubMed  CAS  Google Scholar 

  3. Jones CA, Nyberg L: Epidemiology of interstitial cystitis. Urology 1997, 49(suppl):2–9.

    Article  PubMed  CAS  Google Scholar 

  4. Gillenwater JY, Wein AJ: Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28–29, 1987. J Urol 1988, 140:203–206.

    PubMed  CAS  Google Scholar 

  5. Propert KJ, Schaeffer AJ, Brensinger CM, et al.: A prospective study of interstitial cystitis: results of longitudinal followup of the interstitial cystitis database cohort. The Interstitial Cystitis Data Base Study Group. J Urol 2000, 16:1434–1439.

    Google Scholar 

  6. Held PJ, Hanno PM, Wein AJ, et al.: Epidemiology of interstitial cystitis: In Interstitial Cystitis. Edited by Hanno PM, Statskin DR, Krane RJ, Wein AJ. New York: Springer-Verlag; 1990:29–48.

    Google Scholar 

  7. Curhan GC, Speizer FE, Hunter DJ, et al.: Epidemiology of interstitial cystitis: a population based study. J Urol 1999, 161:549–552.

    Article  PubMed  CAS  Google Scholar 

  8. Elbadawi A: A critique of current concepts with a new proposal for pathological diagnosis and pathogenesis. Urology 1997, 49(suppl):14–40.

    Article  PubMed  CAS  Google Scholar 

  9. Duncan JL, Schaeffer A: Do infectious agents cause interstitial cystitis? Urology 1997, 49(suppl):48–51.

    Article  PubMed  CAS  Google Scholar 

  10. Haarala M, Jalava J, Laato M, et al.: Absence of bacterial DNA in the bladder of patients with interstitial cystitis. J Urol 1996, 156:1843–1845.

    Article  PubMed  CAS  Google Scholar 

  11. Keay S, Zhang CO, Baldwin BR, et al.: Polymerase chain reaction amplification of bacterial 16S rRNA genes in interstitial cystitis and control patient bladder biopsies. J Urol 1998, 159:280–283.

    Article  PubMed  CAS  Google Scholar 

  12. Domingue GJ, Ghoniem GM, Bost KL, et al.: Dormant microbes in interstitial cystitis. J Urol 1995, 153:1321–1326.

    Article  PubMed  CAS  Google Scholar 

  13. Alagiri M, Chottiner S, Ratner V, et al.: Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology 1997, 49(suppl):52–57.

    Article  PubMed  CAS  Google Scholar 

  14. Ochs RL: Autoantibodies and interstitial cystitis. Clin Lab Med 1997, 17:571–579.

    PubMed  CAS  Google Scholar 

  15. Haarala M, Alanen A, Hietarinta M, Kiilholma P: Lower urinary tract symptoms in patients with Sjögren’s syndrome and systemic lupus erythematous. Int Urogynecol J Pelvic Floor Dysfunct 2000, 11:84–86.

    Article  PubMed  CAS  Google Scholar 

  16. Parsons CL: Epithelial coating techniques in the treatment of interstitial cystitis. Urology 1997, 49(suppl):101–104.

    Article  Google Scholar 

  17. Parsons CL: Potassium sensitivity. Tech Urol 1996, 2:171–173.

    PubMed  CAS  Google Scholar 

  18. Teichman JM, Nielsen-Omeis BJ: Potassium leak test predicts outcome in interstitial cystitis. J Urol 1999, 161:1791–1794.

    Article  PubMed  CAS  Google Scholar 

  19. Wei DC, Politano VA, Selzer MG, Lokeshwar VB: The association of elevated urinary total sulfated glycosaminoglycan ratio and high molecular mass hyaluronic acid with interstitial cystitis. J Urol 2000, 163:1577–1583.

    Article  PubMed  CAS  Google Scholar 

  20. Sant GR, Theoharides TC: The role of mast cell in interstitial cystitis. Urol Clin North Am 1994, 21:41–53.

    PubMed  CAS  Google Scholar 

  21. Hofmeister MA, He F, Ratlif TL, et al.: Mast cells and nerve fibers in interstitial cystitis (IC): an algorithm for histologic diagnosis via quantitative image analysis and morphometry (QIAM). Urology 1997, 49(suppl):41–47.

    Article  PubMed  CAS  Google Scholar 

  22. Lavelle JP, Meyers SA, Ruiz WG, et al.: Urothelial pathophysiological changes in feline interstitial cystitis: a human model. Am J Physiol Renal Physiol 2000, 278:F540-F553.

    PubMed  CAS  Google Scholar 

  23. Novicki DE, Larson TR, Swanson SK: Interstitial cystitis in men. Urology 1998, 52:621–624.

    Article  PubMed  CAS  Google Scholar 

  24. Kirkemo A, Peabody M, Diokno AC, et al., and the ICB Study Group: Associations among urodynamic findings and symptoms in women enrolled in the interstitial cystitis data base (ICB) study. Urology 1997, 49(suppl):76–80.

    Article  PubMed  CAS  Google Scholar 

  25. Messing E, Pauk D, Schaeffer A, et al., and the ICB Study Group: Associations among cystoscopic findings and symptoms and physical examination findings in women enrolled in the interstitial cystitis data base (ICB) study. Urology 1997, 49(suppl):81–85.

    Article  PubMed  CAS  Google Scholar 

  26. Waxman JA, Sulak PJ, Kuehl TJ: Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J Urol 1998, 160:1663–1667. The authors found glomerulations in non-IC asymptomatic women undergoing cystoscopy and hydrodistention under 70 cm of water pressure during laparoscopic tubal ligation. This observation has cast doubt on the positive predictive value of glomerulations in the diagnosis of IC.

    Article  PubMed  CAS  Google Scholar 

  27. Chambers GK, Fenster HN, Cripps S, et al.: An assessment of the use of intravesical potassium in the diagnosis of interstitial cystitis. J Urol 1999, 162:699–701. The authors in this study have not found the intravesical KCl test to be useful in the diagnosis of patients with IC. Likelihood ratios indicated poor inclusion and exclusion capabilities. The exact role of intravesical KC in the diagnosis of IC remains to be determined.

    Article  PubMed  CAS  Google Scholar 

  28. O’Leary MP, Sant GR, Fowler FJ, et al.: The interstitial cystitis symptom index and problem index. Urology 1997, 49(suppl):58–63. The IC symptom and problem indices are very useful in the management of patients with IC and should be particularly useful in clinical trials of new therapies for this condition, in which validated and reproducible outcome measures are critically important.

    Article  PubMed  CAS  Google Scholar 

  29. Chaikin DC, Blaivas JG, Blaivas ST: Behavioral therapy for the treatment of refractory interstitial cystitis. J Urol 1993, 149:1445–1448.

    Google Scholar 

  30. Theoharides TC, Sant GR: Hydroxyzine therapy for interstitial cystitis. Urology 1997, 49(suppl):108–110.

    Article  PubMed  CAS  Google Scholar 

  31. Hanno PM: Analysis of long-term Elmiron therapy for interstitial cystitis. Urology 1997, 49(suppl):93–99.

    Article  PubMed  CAS  Google Scholar 

  32. Parsons CL, Benson G, Childs SJ, et al.: A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J Urol 1993, 150:845–848.

    PubMed  CAS  Google Scholar 

  33. Nickel CJ, Payne CK, Forrest J, et al.: Safety and efficacy of 3 doses of pentosanpolysulfate (PPS) in patients with interstitial cystitis [abstract]. J Urol 2000, 163(suppl):63.

    Article  Google Scholar 

  34. Korting GE, Smith SD, Wheeler MA, et al.: A randomized double blind trial of oral L-arginine for treatment of interstitial cystitis. J Urol 1999, 161:558–565.

    Article  PubMed  CAS  Google Scholar 

  35. Brookoff D: The causes and treatment of pain in interstitial cystitis. In Interstitial Cystitis. Edited by Sant GR. New York: Lippincott-Raven; 1997:177–192.

    Google Scholar 

  36. Parkin J, Shea C, Granum RS: Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis—a practical approach. Urology 1997, 49(suppl):105–107.

    Article  PubMed  CAS  Google Scholar 

  37. Parsons CL, Housley T, Schmidt JD, et al.: Treatment of interstitial cystitis with intravesical heparin. Br J Urol 1994, 73:504–507.

    Article  PubMed  CAS  Google Scholar 

  38. Peters KM, Diokno AC, Steinert BW, Gonzalez JA: The efficacy of intravesical bacillus Calmette-Guérin in the treatment of interstitial cystitis: long-term followup. J Urol 1998, 159:1483–1486. The authors previously reported a prospective, double-blind, placebo controlled study of the use of 6 weekly intravesical instillation of bacilles Calmette-Guérin (BCG) in the treatment of IC. The mean follow-up was 8 months. The encouraging results demonstrated a 60% BCG response rate, compared with 27% placebo response rate. In this recent paper, they reported long-term mean follow-up (27 months), eight of nine (89%) of the responders continued to benefit from the therapy. This represents encouraging results in a small group of patients. However, the study design was very satisfactory.

    Article  PubMed  CAS  Google Scholar 

  39. Morales A, Emerson L, Nickel JC: Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. Urology 1997, 49(suppl):111–113.

    Article  PubMed  CAS  Google Scholar 

  40. Fall M, Lindstrom S: Transcutaneous electrical nerve stimulation in classic and nonulcer interstitial cystitis. Urol Clin North Am 1994, 219:131–139.

    Google Scholar 

  41. Peeker R, Aldenborg F, Fall M: The treatment of interstitial cystitis with supratrigonal cystectomy and ileocystoplasty: difference in outcome between classic and nonulcer disease. J Urol 1998, 159:1479–1482.

    Article  PubMed  CAS  Google Scholar 

  42. Baskin LS, Tanagho EA: Pelvic pain without pelvic organs. J Urol 1992, 147:683–686.

    PubMed  CAS  Google Scholar 

  43. Webster GD, MacDiarmid SA, Timmons SL: Impact of urinary diversion procedures in the treatment of interstitial cystitis and chronic bladder pain. Neurourol Urodyn 1992, 11:417–419.

    Google Scholar 

  44. Chai TC, Zhang C, Warren JW, Keay S: Percutaneous sacral third nerve root neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in patients with interstitial cystitis. Urology 2000, 55:643–646.

    Article  PubMed  CAS  Google Scholar 

  45. Propert KJ, Schaeffer AJ, Brensinger CM, et al.: A prospective study of interstitial cystitis: results of longitudinal follow-up of the interstitial cystitis database cohort. The Interstitial Cystitis DataBase Study Group. J Urol 2000, 163:1434–1439. A total of 637 eligible patients were entered into the study and were followed for symptoms of pain, urgency, and urinary frequency. Median follow-up was 31 months. Median duration of IC symptoms was 8 years. Although all symptoms fluctuated, there was no evidence of significant long-term change in overall disease severity. The observations support the clinical observation that IC is a chronic disease and that no current treatments have a significant impact on symptoms with time.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of Miami, PO Box 016960 (M814), 33101, Miami, FL, USA

    Angelo E. Gousse MD, Rabi Tiguert MD & Shahar Madjar MD

Authors
  1. Angelo E. Gousse MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rabi Tiguert MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shahar Madjar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gousse, A.E., Tiguert, R. & Madjar, S. Current investigations and treatment of interstitial cystitis. Curr Urol Rep 1, 190–198 (2000). https://doi.org/10.1007/s11934-000-0018-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-000-0018-0

Keywords

Search

Navigation